Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors

Clinical trial NCT00227617 · TERMINATED

Trial details

NCT number: NCT00227617
Sponsor: University of California, San Francisco
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Gastrointestinal Carcinoid Tumor Islet Cell Tumor Lung Cancer Neoplastic Syndrome Neuroendocrine Tumor

Start date: 2005-06-08
Primary completion: 2012-01-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.